By Matthew Carulli, Project Director, TransPerfect Linguistic Validation
With so many clinical trials now using COAs on electronic platforms, the practice of “migration” (transferring and adapting COAs for electronic use) has become more common than ever.
Without careful implementation, one minor deviation can compound across many languages, leading to delays in FPFV or, if not caught prior to deployment, data integrity issues.
If these types of issues are discovered and corrected before the translation process begins, it can prevent the need for a COA source update during translation, saving your budget and timelines in upcoming global clinical trials.
Possible Migration Issues
The time to begin paying attention to eCOA migration is during the very start of project planning with your eCOA vendor. Following are some common errors that may arise if the migration is not prepared fully and thoroughly.